Virtual screening FDA approved drugs against multiple targets of SARS‐CoV‐2

The outbreak of the novel coronavirus severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2), the causative agent of coronavirus disease 2019 (COVID‐19) respiratory disease, led to a global pandemic with high morbidity and mortality. Despite frenzied efforts in therapeutic development, there a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Hualou, Zhao, Liang, Gong, Xiajing, Hu, Meng, Wang, Hongbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014887/
https://www.ncbi.nlm.nih.gov/pubmed/33606912
http://dx.doi.org/10.1111/cts.13007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014887/
https://www.ncbi.nlm.nih.gov/pubmed/33606912
http://dx.doi.org/10.1111/cts.13007

Ejemplares similares